Cheng G - Search Results

1

The tailored chemotherapy based on RRM1 immunohistochemical expression in patients with advanced non-small cell lung cancer.

Nie X, Cheng G, Ai B, Zhang S. Nie X, et al. Among authors: cheng g. Cancer Biomark. 2013 Jan 1;13(6):433-40. doi: 10.3233/CBM-130381. Cancer Biomark. 2013. PMID: 24595080 Clinical Trial.

2

Epidermal growth factor receptor mutation analysis in cytological specimens and responsiveness to gefitinib in advanced non-small cell lung cancer patients.

Li L, Zhang Z, Bie Z, Wang Z, Zhang P, Nie X, Li Y, Wang H, Ai B, Cheng G. Li L, et al. Among authors: cheng g. Chin J Cancer Res. 2015 Jun;27(3):294-300. doi: 10.3978/j.issn.1000-9604.2015.05.03. Chin J Cancer Res. 2015. PMID: 26157326 Free PMC article.

3

Survival analysis for older patients with epidermal growth factor receptor mutation-positive advanced non-small cell lung cancer after progression of first-line gefitinib.

Nie X, Zhang P, Cheng G, Wu XN, Li L. Nie X, et al. Among authors: cheng g. Asia Pac J Clin Oncol. 2022 Feb;18(1):150-155. doi: 10.1111/ajco.13546. Epub 2021 Apr 27. Asia Pac J Clin Oncol. 2022. PMID: 33904654

4

Sarcopenia as a predictor of initial administration dose of afatinib in patients with advanced non-small cell lung cancer.

Nie X, Zhang P, Gao JY, Cheng G, Liu W, Li L. Nie X, et al. Among authors: cheng g. Thorac Cancer. 2021 Jun;12(12):1824-1830. doi: 10.1111/1759-7714.13934. Epub 2021 May 5. Thorac Cancer. 2021. PMID: 33951292 Free PMC article.

5

[Drug therapy of advanced non-small cell lung cancer in the elderly].

Ai B, Cheng G. Ai B, et al. Among authors: cheng g. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010 Aug;32(4):473-6. doi: 10.3881/j.issn.1000-503X.2010.04.025. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2010. PMID: 20868614 Review. Chinese.

6

Clinical analysis of 64 patients with lung-cancer-associated hypercalcemia.

Li X, Bie Z, Zhang Z, Li Y, Hu X, Liu W, Zhang S, Cheng G, Ai B. Li X, et al. Among authors: cheng g. J Cancer Res Ther. 2015 Nov;11 Suppl:C275-9. doi: 10.4103/0973-1482.170539. J Cancer Res Ther. 2015. PMID: 26612452 Free article.

7

From focal pulmonary pure ground-glass opacity nodule detected by low-dose computed tomography into invasive lung adenocarcinoma: A growth pattern analysis in the elderly.

Nie X, Li L, Huang J, Zhang P, Shi H, Cheng G, Zhang YQ. Nie X, et al. Among authors: cheng g. Thorac Cancer. 2018 Nov;9(11):1361-1365. doi: 10.1111/1759-7714.12829. Epub 2018 Aug 24. Thorac Cancer. 2018. PMID: 30144287 Free PMC article.

8

Prognostic value of the baseline circulating T cell receptor β chain diversity in advanced lung cancer.

Wang J, Bie Z, Zhang Y, Li L, Zhu Y, Zhang Y, Nie X, Zhang P, Cheng G, Di X, Li X, Cheng S, Feng L. Wang J, et al. Among authors: cheng g, cheng s. Oncoimmunology. 2021 Mar 17;10(1):1899609. doi: 10.1080/2162402X.2021.1899609. Oncoimmunology. 2021. PMID: 33796410 Free PMC article.

9

Phase I safety and pharmacokinetic study of bevacizumab in Chinese patients with advanced cancer.

Wu JY, Wu XN, Ding L, Zhao YB, Ai B, Li Y, Hu X, Cheng G. Wu JY, et al. Among authors: cheng g. Chin Med J (Engl). 2010 Apr 5;123(7):901-6. Chin Med J (Engl). 2010. PMID: 20497685 Clinical Trial.

10

Late recurrence and metastasis of an appendiceal goblet cell carcinoid 24 years after appendectomy.

Tang M, Ai B, Ding L, Du J, Cheng G, Zhang Y. Tang M, et al. Among authors: cheng g. Chin Med J (Engl). 2014;127(3):591-2. Chin Med J (Engl). 2014. PMID: 24451973 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,914 results

Search Page

Filters